Back to top

4D Molecular initiated with a Buy at B. Riley

B. Riley initiated coverage of 4D Molecular (FDMT) with a Buy rating and $37 price target. 4D-150 is a one-time eye injection that makes the eye pr...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

4D Molecular Therapeutics, Inc. (FDMT)

Eli Lilly and Company (LLY)